<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83827">
  <stage>Registered</stage>
  <submitdate>17/04/2009</submitdate>
  <approvaldate>27/05/2009</approvaldate>
  <actrnumber>ACTRN12609000366257</actrnumber>
  <trial_identification>
    <studytitle>Effects of parenteral protein intake in intensive care patients</studytitle>
    <scientifictitle>Nutritional status and outcomes in critically ill patients receiving a standard or a high-protein parenteral nutrition triple-phase solution</scientifictitle>
    <utrn />
    <trialacronym>EPPII</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>critical illness</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients requiring intravenous (parenteral) nutrition in the intensive care unit will be randomised to receive one of two triple phase parenteral nutrition solutions for the duration of their need for parenteral nutrition while in the intensive care unit. The protein in the parenteral nutrition solution is in the form of a balanced set of amino acids. The higher-protein intervention solution has 53g of amino acids per 1000kcal.</interventions>
    <comparator>Patients requiring intravenous (parenteral) nutrition in the intensive care unit will be randomised to receive one of two triple phase parenteral nutrition solutions for the duration of their need for parenteral nutrition while in the intensive care unit. The protein in the parenteral nutrition solution is in the form of a balanced set of amino acids. The lower-protein control solution is similar to the standard product currently used in the intensive care unit, with 39g of amino acids per 1000kcal.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>nitrogen balance measured using a 24-hour urine collection to calculate 24-hour urinary urea nitrogen excretion and compare with nitrogen intake from the parenteral nutrition solution.</outcome>
      <timepoint>after 5 days on parenteral nutrition</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>handgrip dynamometer measurement</outcome>
      <timepoint>on discharge from the intensive care unit</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>adult intensive care patients requiring parenteral nutrition - our intensive care unit is an adult unit by Department of Health criteria, that is it accepts patients from 16 years upwards and all patients in the unit will be eligible for the study.</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>patients under 16 years of age</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>consecutive patients requiring parenteral nutrition will be enrolled and randomised to standard or high-protein parenteral nutrition with retrospective consent. Parenteral nutrition solutions will be concealed by sealed identical light-protective covers.</concealment>
    <sequence>Computerised sequence generation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>30/06/2009</anticipatedstartdate>
    <actualstartdate>25/11/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>30/11/2014</actualenddate>
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Royal Prince Alfred Hospital - Camperdown</hospital>
    <postcode>2050 - Camperdown</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Royal Prince Alfred Hospital</primarysponsorname>
    <primarysponsoraddress>Missenden Road
Camperdown NSW 2050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Sydney</sponsorname>
      <sponsoraddress>City Road,
University of Sydney
UNIVERSITY OF SYDNEY
NSW 2006</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>There is no good evidence to support any particular level of protein input in critical illness. Some studies have indicated a level above which there is no additional benefit to short-term indicators (such as nitrogen balance), but none of the studies have looked at the effects on concrete outcomes such as time in the intensive care unit, or functional measures after discharge. The aim of this study is to look at such concrete measures after administering two different levels of protein to patients who are fed intravenously. The hypothesis is that a higher level of protein will improve outcomes.</summary>
    <trialwebsite />
    <publication>no publications as yet</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney South West Area Health Service Ethics Review Committee (Royal Prince Alfred Hospital zone)</ethicname>
      <ethicaddress>Royal Prince Alfred Hospital
Missenden Road
CAMPERDOWN   NSW 2050</ethicaddress>
      <ethicapprovaldate>16/11/2009</ethicapprovaldate>
      <hrec>X09-0228 &amp; HREC/09/RPAH/373</hrec>
      <ethicsubmitdate>20/04/2009</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Ms</title>
      <name>Suzie Ferrie</name>
      <address>Department of Nutrition &amp; Dietetics
Royal Prince Alfred Hospital
Missenden Road
CAMPERDOWN  NSW 2050</address>
      <phone>+61 2 95158053</phone>
      <fax />
      <email>suzie.ferrie@sswahs.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Suzie Ferrie</name>
      <address>Department of Nutrition &amp; Dietetics
Royal Prince Alfred Hospital
Missenden Road
CAMPERDOWN  NSW 2050</address>
      <phone>+61 2 95158053</phone>
      <fax />
      <email>suzie.ferrie@sswahs.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Suzie Ferrie</name>
      <address>Department of Nutrition &amp; Dietetics
Royal Prince Alfred Hospital
Missenden Road
CAMPERDOWN  NSW 2050</address>
      <phone>+61 2 95158053</phone>
      <fax />
      <email>suzie.ferrie@sswahs.nsw.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Suzie Ferrie</name>
      <address>Department of Nutrition &amp; Dietetics
Royal Prince Alfred Hospital
Missenden Road
CAMPERDOWN   NSW 2050</address>
      <phone>+ 61 2 9515 8053</phone>
      <fax />
      <email>suzie.ferrie@sswahs.nsw.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>